The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Michael David since 2021.
This trader's CIK number is 1777800.
At the time of last reporting, Smith Michael David was the Senior VP, Development of Kalvista Pharmaceuticals, Inc.. (stock ticker symbol KALV).
Also see all insider trading activities at Kalvista Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | KALV | 0 | $0 | 17,514 | $459,205 | 17,514 | $146,942 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-01 | KALV | Sale | 7,500 | 26.83 | 201,225 |
| 2021-06-01 | KALV | Option Ex | 7,500 | 8.39 | 62,925 |
| 2021-04-28 | KALV | Sale | 10,014 | 25.76 | 257,980 |
| 2021-04-28 | KALV | Option Ex | 10,014 | 8.39 | 84,017 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Michael David (Senior VP, Development of Kalvista Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.